Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.280
+0.020 (1.59%)
Oct 30, 2026, 3:00 PM CST

Kangmei Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,8205,2525,1894,8744,1804,153
Revenue Growth
-8.63%1.22%6.46%16.60%0.66%-23.27%
Gross Profit
950.69948.5653.37728.86431.1491.52
Operating Income
-243.09-221.55-413.53179.59-1,040-3,046
Net Income
90.6510.338.57102.52-2,6887,918
Earnings Per Share
0.010.000.000.01-0.190.57
EPS Growth
370.66%16.67%-94.00%---

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Traditional Chinese Medicine, Western Medicine and Medical Devices
4,2194,2413,8763,4343,407
Health Food and Food
500.27437.48502.79324.58184.23
Property Leasing and Sales and Others
532.62510.55494.89421.95560.99
Total
5,2525,1894,8744,1804,153

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3631,240977.921,0571,5082,419
Total Debt
152.27184.36139.13255.01263.87205.29
Net Cash (Debt)
1,2111,056838.8801.681,2442,214
Net Cash Growth
14.01%25.87%4.63%-35.54%-43.82%-
Net Cash Per Share
0.080.070.060.080.090.16

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
71.35111.35-427.63-317.52-749.96214.21
Capital Expenditures
-186.51-217.06-61.71-99.74-48.12-171.63
Free Cash Flow
-115.16-105.71-489.34-417.27-798.0842.58
Free Cash Flow Growth
------94.16%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
19.72%18.06%12.59%14.95%10.31%2.20%
Operating Margin
-5.04%-4.22%-7.97%3.69%-24.89%-73.37%
Pretax Margin
2.36%0.82%0.67%2.26%-63.73%196.39%
Profit Margin
1.88%0.20%0.17%2.10%-64.31%190.68%
FCF Margin
-2.39%-2.01%-9.43%-8.56%-19.09%1.03%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
226.072557.443783.85251.53-5.41
Forward PE
-2.562.562.562.562.56
P/FCF Ratio
-----1006.12
PS Ratio
3.675.036.255.297.3010.32